As an H2-receptor antagonist, famotidine competitively blocks histamine H2 receptors on gastric parietal cells to reduce acid secretion
By mimicking GLP-1, tirzepatide increases insulin secretion, reduces glucagon release, and slows gastric emptying
The Hormone-Aware Metabolic Framework GLP-1 microdosing should be evaluated within a structured order of metabolic care rather than as a stand-alone dosing experiment
In clinical trials, patients on Wegovy, combined with lifestyle changes, lost on average: 15% of their body weight over 68 weeks
- to the intravenous injection route:
The test reveals genetic variants in GLP-1 receptor, FTO, MC4R, and GIPR pathways that may correlate with typical or atypical appetite suppression patterns